Rethinking aid-in-dying medications
Doctors in the Northwest are once again rethinking aid-in-dying medications because they’re taking too long to work.
Doctors in the Northwest are once again rethinking aid-in-dying medications because they’re taking too long to work.
“This is really an amazing opportunity to be part of establishing policy and initiating something in medicine. This is a major change … [that] very, very few people know anything about and how to do it.”
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Elizabeth Wallner, diagnosed with Stage 4 colon cancer five years ago, has one word to describe the pharmaceutical executive who decided to double the price of Seconal: “Scumbag.”
The pending dismissal is a setback for aid-in-dying advocates, who argue that physicians should be able to prescribe life-ending medications for terminally ill patients who request them to avoid unnecessary suffering.